These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19506877)

  • 1. Adalimumab in the therapy of uveitis in childhood.
    Biester S; Deuter C; Michels H; Haefner R; Kuemmerle-Deschner J; Doycheva D; Zierhut M
    Br J Ophthalmol; 2007 Mar; 91(3):319-24. PubMed ID: 17035274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adalimumab induced psoriasis in a Crohn's disease patient: A case report.
    Alenizi D
    J Pak Med Assoc; 2024 Jul; 74(7):1361-1363. PubMed ID: 39028072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile Idiopathic Arthritis With Associated Inflammatory Bowel Disease and CARD8 Mutation.
    Gennaro VL; Maclin J; Weiser P; Stoll ML; Smitherman EA
    Pediatrics; 2023 Oct; 152(4):. PubMed ID: 37724393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of two hepatitis A vaccine doses among adolescents with juvenile idiopathic arthritis and Crohn's disease on immunosuppressive therapy: a pilot study.
    Githumbi R; Kuhn S; Osiowy C; Day J; deBruyn JCC; Fritzler MJ; Johnson NA; Vanderkooi O; Schmeling H
    J Travel Med; 2024 Jun; 31(4):. PubMed ID: 38652172
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor-necrosis factor α-rich environment alters type-I interferon response to viral stimuli in patients with juvenile idiopathic arthritis by altering myeloid dendritic cell phenotype.
    Zentsova I; Klocperk A; Bloomfield M; Kubesova H; Malcova H; Cebecauerova D; Horvath R; Sediva A; Parackova Z
    Clin Immunol; 2024 May; 262():110170. PubMed ID: 38460895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of anti-TNFα medications for rheumatologic disease in pregnancy.
    Clowse ME
    Int J Womens Health; 2010 Aug; 2():199-209. PubMed ID: 21072312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment-A Review.
    Mihai IR; Burlui AM; Rezus II; Mihai C; Macovei LA; Cardoneanu A; Gavrilescu O; Dranga M; Rezus E
    Life (Basel); 2023 Aug; 13(8):. PubMed ID: 37629636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.
    Verazza S; Davì S; Consolaro A; Bovis F; Insalaco A; Magni-Manzoni S; Nicolai R; Marafon DP; De Benedetti F; Gerloni V; Pontikaki I; Rovelli F; Cimaz R; Marino A; Zulian F; Martini G; Pastore S; Sandrin C; Corona F; Torcoletti M; Conti G; Fede C; Barone P; Cattalini M; Cortis E; Breda L; Olivieri AN; Civino A; Podda R; Rigante D; La Torre F; D'Angelo G; Jorini M; Gallizzi R; Maggio MC; Consolini R; De Fanti A; Muratore V; Alpigiani MG; Ruperto N; Martini A; Ravelli A;
    Pediatr Rheumatol Online J; 2016 Dec; 14(1):68. PubMed ID: 27993144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory Bowel Disease Provoked by Etanercept: Report of 443 Possible Cases Combined from an IBD Referral Center and the FDA.
    O'Toole A; Lucci M; Korzenik J
    Dig Dis Sci; 2016 Jun; 61(6):1772-4. PubMed ID: 26728477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Onset, Aggravation and Recurrence of Crohn's Disease upon Treatment with Three Different Tumor Necrosis Factor Inhibitors.
    Zeitz J; Enderlin S; Biedermann L; Turina M; Leibl S; Prakash M; Rogler G; Misselwitz B
    Case Rep Gastroenterol; 2015; 9(1):106-12. PubMed ID: 26034472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the likelihood of new-onset inflammatory bowel disease following tumor necrosis factor-alpha inhibitor therapy for rheumatoid arthritis and juvenile rheumatoid arthritis.
    Krishnan A; Stobaugh DJ; Deepak P
    Rheumatol Int; 2015 Apr; 35(4):661-8. PubMed ID: 25228459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of etanercept in the treatment of arthritides in children and adolescents.
    Dore RK
    Adolesc Health Med Ther; 2014; 5():35-48. PubMed ID: 24729739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crohn's disease unmasked following etanercept treatment for ankylosing spondylitis.
    Jethwa H; Mann S
    BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23813506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety profile of biologic therapies for juvenile idiopathic arthritis.
    Hashkes PJ; Uziel Y; Laxer RM
    Nat Rev Rheumatol; 2010 Oct; 6(10):561-71. PubMed ID: 20808294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature.
    Wiegering V; Morbach H; Dick A; Girschick HJ
    Rheumatol Int; 2010 Apr; 30(6):801-4. PubMed ID: 19506877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of Crohn's disease in juvenile idiopathic arthritis during treatment with etanercept: a causal link or a mere coincidence?
    Oikonomou KA; Kapsoritakis AN; Tsiopoulos FD; Tsikouras AN; Potamianos S
    J Gastrointestin Liver Dis; 2010 Sep; 19(3):342. PubMed ID: 20922209
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series.
    Toussirot É; Houvenagel É; Goëb V; Fouache D; Martin A; Le Dantec P; Dernis E; Wendling D; Ansemant T; Berthelot JM; Bader-Meunier B; Kantelip B;
    Joint Bone Spine; 2012 Oct; 79(5):457-63. PubMed ID: 22088934
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.